Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical-Size Muscle Defect Regeneration Using an Injectable Cell-Laden Nanofibrous Matrix: An Ex Vivo Mouse Hindlimb Organ Culture Study.

International journal of molecular sciences·2025
Same author

Protocol for quantifying the horizontal and vertical distribution of junctional proteins in fixed epithelial cells.

STAR protocols·2025
Same author

Quantification of horizontal and vertical distribution of junctional proteins in fixed epithelial cells.

bioRxiv : the preprint server for biology·2025
Same author

Synergetic role of TRPV4 inhibitor and mechanical loading on reducing inflammation.

Frontiers in immunology·2025
Same author

Tideglusib enhances ALP activity and upregulates RANKL expression in Osteoblast-macrophage Co-cultures within a 3D collagen scaffold.

Journal of dentistry·2024
Same author

The Scribble-SGEF-Dlg1 complex regulates E-cadherin and ZO-1 stability, turnover and transcription in epithelial cells.

Journal of cell science·2024

Related Experiment Video

Updated: Jun 7, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

8.4K

Immunomodulation Through Fibroblast-Derived Extracellular Vesicles (EVs) Within 3D Polycaprolactone-Collagen Matrix.

Afsara Tasnim1, Diego Jacho1, Agustin Rabino2

  • 1Department of Bioengineering, University of Toledo, Toledo, OH 43606, USA.

Biomimetics (Basel, Switzerland)
|August 27, 2025
PubMed
Summary

Human fibroblast extracellular vesicles (EVs) in injectable scaffolds reprogram macrophages to reduce inflammation and maintain tissue engineering scaffold integrity. This cell-free approach enhances regenerative medicine potential.

Keywords:
collagenextracellular vesiclesfibroblastsimmunomodulationinflammationmacrophagespolycaprolactonetissue regeneration

More Related Videos

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
11:19

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms

Published on: April 11, 2017

13.5K
Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

7.6K

Related Experiment Videos

Last Updated: Jun 7, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

8.4K
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
11:19

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms

Published on: April 11, 2017

13.5K
Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

7.6K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Immunomodulation

Background:

  • Extracellular vesicles (EVs) are acellular tools for immune modulation in tissue engineering.
  • Human fibroblast-derived EVs show potential for therapeutic applications.
  • Scaffold integrity and immune response are critical for regenerative therapies.

Purpose of the Study:

  • To investigate fibroblast-derived EVs within a 3D injectable scaffold (PNCOL) for modulating macrophage behavior.
  • To assess the impact of EVs on scaffold integrity under inflammatory conditions.
  • To evaluate the potential of this cell-free approach for regenerative medicine.

Main Methods:

  • Isolation and characterization of human fibroblast-derived EVs.
  • Preparation of macrophage-laden PNCOL scaffolds with different conditions (MP, F-MP, EV-MP).
  • Assessment of scaffold structure (SEM, Masson's trichrome) and immunomodulatory effects (metabolic assays, gene expression, IHC for M1/M2 markers).

Main Results:

  • Fibroblast-derived EVs preserved scaffold structure and enhanced macrophage metabolic activity.
  • EV-encapsulated scaffolds showed upregulation of anti-inflammatory markers (TGF-β, CD163, CCL18) and CD206.
  • A phenotypic shift towards M2-like macrophages was observed in EV-encapsulated scaffolds.

Conclusions:

  • Fibroblast-derived EVs in injectable PCL-collagen scaffolds offer a cell-free method to modulate inflammation.
  • This strategy preserves scaffold structure and supports regenerative healing.
  • The approach shows promise for immuno-instructive platforms in regenerative medicine.